238 related articles for article (PubMed ID: 2685419)
1. [Molecular heterogeneity of the bullous pemphigoid antigen as detected by immunoblotting].
Izumi H; Hosokawa H
Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):871-5. PubMed ID: 2685419
[TBL] [Abstract][Full Text] [Related]
2. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
Labib RS; Anhalt GJ; Patel HP; Mutasim DF; Diaz LA
J Immunol; 1986 Feb; 136(4):1231-5. PubMed ID: 2418109
[TBL] [Abstract][Full Text] [Related]
3. A 230-kD basic protein is the major bullous pemphigoid antigen.
Mueller S; Klaus-Kovtun V; Stanley JR
J Invest Dermatol; 1989 Jan; 92(1):33-8. PubMed ID: 2462597
[TBL] [Abstract][Full Text] [Related]
4. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
Zhu XJ; Niimi Y; Bystryn JC
J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
[TBL] [Abstract][Full Text] [Related]
5. Western blot analysis of the antigen in pemphigoid gestationis.
Kelly SE; Bhogal BS; Wojnarowska F; Whitehead P; Leigh IM; Black MM
Br J Dermatol; 1990 Apr; 122(4):445-9. PubMed ID: 2186774
[TBL] [Abstract][Full Text] [Related]
6. Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins.
Tanaka M; Hashimoto T; Amagai M; Shimizu N; Ikeguchi N; Tsubata T; Hasegawa A; Miki K; Nishikawa T
J Invest Dermatol; 1991 Oct; 97(4):725-8. PubMed ID: 1940445
[TBL] [Abstract][Full Text] [Related]
7. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens.
Robledo MA; Kim SC; Korman NJ; Stanley JR; Labib RS; Futamura S; Anhalt GJ
J Invest Dermatol; 1990 Jun; 94(6):793-7. PubMed ID: 2192002
[TBL] [Abstract][Full Text] [Related]
8. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
[TBL] [Abstract][Full Text] [Related]
9. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.
Hamada T; Nagata Y; Tomita M; Salmhofer W; Hashimoto T
Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314
[TBL] [Abstract][Full Text] [Related]
10. Comparative expression of bullous pemphigoid antigens in normal human epidermis and cultured keratinocytes.
Su H; Reano A; Viac J; Thivolet J
Clin Immunol Immunopathol; 1989 Jun; 51(3):406-13. PubMed ID: 2656012
[TBL] [Abstract][Full Text] [Related]
11. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
[TBL] [Abstract][Full Text] [Related]
12. The role of bullous pemphigoid antibodies in dermal-epidermal separation.
Haustein UF
J Invest Dermatol; 1989 Jan; 92(1):133. PubMed ID: 2642509
[No Abstract] [Full Text] [Related]
13. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2.
Haase C; Büdinger L; Borradori L; Yee C; Merk HF; Yancey K; Hertl M
J Invest Dermatol; 1998 Mar; 110(3):282-6. PubMed ID: 9506450
[TBL] [Abstract][Full Text] [Related]
14. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies.
Stanley JR; Tanaka T; Mueller S; Klaus-Kovtun V; Roop D
J Clin Invest; 1988 Dec; 82(6):1864-70. PubMed ID: 2461961
[TBL] [Abstract][Full Text] [Related]
15. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
Allen J; Shears E; Powell J; Wojnarowska F
Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
Domloge-Hultsch N; Utecht L; James W; Yancey KB
Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistologic detection of bullous pemphigoid antigen in malignant melanoma].
Hamm G; Reiss CJ
Dermatol Monatsschr; 1985; 171(12):788-92. PubMed ID: 3912222
[No Abstract] [Full Text] [Related]
18. Bullous pemphigoid antibodies.
Accetta PJ; Tarfare N; Helm F; Beutner EH
Arch Dermatol; 1986 May; 122(5):505. PubMed ID: 3085598
[No Abstract] [Full Text] [Related]
19. IgG and IgA antibodies in linear IgA/IgG bullous dermatosis target the ectodomain of bullous pemphigoid antigen 2.
Hertl M; Büdinger L; Christophoridis S; Yancey KB; Borradori L
Br J Dermatol; 1999 Apr; 140(4):750-2. PubMed ID: 10233336
[No Abstract] [Full Text] [Related]
20. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
Ghohestani RF; Claudy A
Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
